Taiwan FDA Amends Cosmetic Scope and Categories Table, Effective 1 July 2026

Expert-linked peers first; others are suggested from shared market or topic tags. Not an official “same regulation” claim.

• Suggested August 25, 2026 MEDIUM
  Repeal of the Standards for Fees for Review of Drug and Cosmetic Registration Applications by the Department of Health, Executive Yuan
• Suggested August 25, 2026 MEDIUM
  Amendment to the Second Point and Its Appendix of the ‘Documents to Be Submitted for Case-by-Case Review of the Use of Exosomes Derived from Human Cells in Cosmetics’, Effective from the Date of Issuance